David T. Teachey - Dissemin

Papers authored by David T. Teachey

This paper is made freely available by the publisher.

2015 Shannon L. Maude, David T. Teachey

, David L. Porter, Stephan A. Grupp

CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

Download from ashpublications.org

M. A. Pulsipher, B. Langholz, D. A. Wall, K. R. Schultz, N. Bunin, W. Carroll, E. Raetz, S. Gardner, R. K. Goyal, J. Gastier-Foster, M. Borowitz, D. Teachey

, S. A. Grupp

Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?

Download from www.nature.com

Shannon L. Maude, Sibasish Dolai, Cristina Delgado-Martin, Tiffaney Vincent, Alissa Robbins, Arthavan Selvanathan, Theresa Ryan, Junior Hall, Andrew C. Wood, Sarah K. Tasian, Stephen P. Hunger, Mignon L. Loh, Charles G. Mullighan, Brent L. Wood, Michelle L. Hermiston and 3 other authors

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia

Download from ashpublications.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

M. C. Milone, Fish, C. Carpenito, R. G. Carroll, G. K. Binder, D. Teachey

, M. Samanta, M. Lakhal, B. Gloss, G. Danet-Desnoyers, D. Campana, J. L. Riley

, S. A. Grupp, C. H. June

Erratum: Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo (Molecular Therapy (2009) 17 (1453-1464) DOI: 10.1038/mt.2009.83)

Upload

This paper is available in a repository.

2014 Shannon L. Maude, Noelle Frey, Pamela A. Shaw, Richard Aplenc, David M. Barrett, Nancy J. Bunin, Anne Chew, Vanessa E. Gonzalez, Zhaohui Zheng, Simon F. Lacey, Yolanda D. Mahnke, Jan J. Melenhorst, Susan R. Rheingold, Angela Shen, David T. Teachey

and 4 other authors

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Download from www.ncbi.nlm.nih.gov

Courtney L. Jones, Teena Bhatla, Roy Blum, Jinhua Wang, Steven W. Paugh, Xin Wen, Wallace Bourgeois, Danielle S. Bitterman, Elizabeth A. Raetz, Debra J. Morrison, David T. Teachey

, William E. Evans, Michael J. Garabedian, William L. Carroll

Loss of TBL1XR1 Disrupts Glucocorticoid Receptor Recruitment to Chromatin and Results in Glucocorticoid Resistance in a B-Lymphoblastic Leukemia Model

Download from doi.org

Sarah K. Tasian

, David T. Teachey

, Susan R. Rheingold

Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies

Download from doi.org

Michael A. Pulsipher, Bryan Langholz, Donna A. Wall, Kirk R. Schultz, Nancy Bunin, William L. Carroll, Elizabeth Raetz, Sharon Gardner, Julie M. Gastier-Foster, Denise Howrie, Rakesh K. Goyal, James G. Douglas, Michael Borowitz, Yvonne Barnes, David T. Teachey

and 2 other authors

The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial

Download from ashpublications.org

David T. Teachey

Targeting cytokines in ALPS: it's FAShionable

Download from ashpublications.org

David M. Barrett, David T. Teachey

, Stephan A. Grupp

Toxicity management for patients receiving novel T-cell engaging therapies

Download from www.ncbi.nlm.nih.gov

Shannon L. Maude, David Barrett, David T. Teachey

, Stephan A. Grupp

Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies

Download from www.ncbi.nlm.nih.gov

2013 David T. Teachey

, Michele P. Lambert

Diagnosis and Management of Autoimmune Cytopenias in Childhood

Download from europepmc.org

This paper was not found in any repository, but could be made available legally by the author.

Benjamin R. Oshrine, Yimei Li, David T. Teachey

, Jennifer Heimall, David M. Barrett, Nancy Bunin

Immunologic Recovery in Children after Alternative Donor Allogeneic Transplantation for Hematologic Malignancies: Comparison of Recipients of Partially T Cell–Depleted Peripheral Blood Stem Cells and Umbilical Cord Blood

Upload

David T. Teachey

, Stephen P. Hunger

Predicting relapse risk in childhood acute lymphoblastic leukaemia

Upload

David T. Teachey

, Susan R. Rheingold, Shannon L. Maude, Gerhard Zugmaier, David M. Barrett, Alix E. Seif, Kim E. Nichols, Erica K. Suppa, Michael Kalos, Robert A. Berg, Julie C. Fitzgerald

, Richard Aplenc, Lia Gore, Stephan A. Grupp

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

Download from ashpublications.org

DeepakBabu Chellapandian, Rupali Das, Kristin Zelley, Susan J. Wiener, Huaqing Zhao, David T. Teachey

, Kim E. Nichols

Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens

Download from www.ncbi.nlm.nih.gov

Stephan A. Grupp, Michael Kalos, David Barrett, Richard Aplenc, David L. Porter, Susan R. Rheingold, David T. Teachey

, Anne Chew, Bernd Hauck, J. Fraser Wright, J. Fraser Wright, Michael C. Milone, Bruce L. Levine, Carl H. June, Others

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Download from www.ncbi.nlm.nih.gov

2012 Shannon L. Maude, Sarah K. Tasian

, Tiffaney Vincent, Junior W. Hall, Cecilia Sheen, Kathryn G. Roberts, Alix E. Seif, David M. Barrett, I.-Ming Chen, I. Ming Chen, J. Racquel Collins, J. Racquel Collins, Charles G. Mullighan, Stephen P. Hunger, Richard C. Harvey

and 5 other authors

Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia

Download from ashpublications.org

David Barrett, Valerie I. Brown, Stephan A. Grupp, David T. Teachey

Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

Download from link.springer.com

Yael P. Mossé, Emily Lipsitz, Elizabeth Fox, David T. Teachey

, John M. Maris, Brenda Weigel, Peter C. Adamson, Mark A. Ingle, Charlotte H. Ahern, Susan M. Blaney

Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Consortium Study

Download from aacrjournals.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by David T. Teachey